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V 
The ‘protein folding problem’, i.e. understanding the detailed steps of the protein 
folding pathways is one of the most challenging topics in biochemistry. Combining 
theoretical with experimental research became indispensable for the investigation of 
the mechanisms in protein folding reactions.   
Here, the biophysical characterization of designed ankyrin repeat (AR) proteins and 
the analysis of the experimental data by theoretical models are presented. Repeat 
proteins comprise repeating structural units that form linear multirepeat arrays. The 
non-globular elongated structure distinguishes them fundamentally from most studied 
proteins and makes repeat proteins interesting for folding studies.  
In previous work, a full-consensus ankyrin repeat had been designed. This idealized 
ankyrin repeat served as a model repeat to study the folding of ankyrin repeat 
proteins. 
In the first part of the thesis, a series of six designed ankyrin repeat proteins 
(DARPins with 1 up to 6 full-consensus repeats and two terminal capping repeats) 
was constructed and analyzed using light scattering, circular dichroism and 
fluorescence spectroscopy. The longer DARPins (> 5 repeats) were so stable that they 
could not be fully unfolded by GdnHCl. Therefore, kinetic analysis was performed 
only with the shorter three DARPins. The chevron plots clearly show deviations from 
the two-state model of folding. Cooperative folding models suggest a three-state 
mechanism with on-pathway intermediate; however, the full analysis of the 
equilibrium data of all six DARPins as well as the kinetic data of the smaller three 
DARPins using an Ising-like model provides further insights into possible parallel 
folding pathways. This model allows drawing an energy landscape for the DARPins 
at each denaturant concentration. Importantly, at high denaturant concentrations, an 
intermediate state with folded repeats and just the capping repeats unfolded would be 
almost as stable as the fully unfolded protein. 
In the second part of the thesis a series of DARPins without capping repeats was 
constructed as well as variants with modified C-terminal capping repeats. The 
importance of the capping repeats for solubility and for avoiding aggregation was 
demonstrated. The C-terminal capping repeat was observed to denature first in MD 
simulations. Thus, a C-cap conferring similar solubility and even higher stability was 
designed, predicted in silico and validated experimentally. NI3C showed a stable 
intermediate in experimental equilibrium unfolding. On the basis of the simulation 
results, this intermediate was interpreted to represent a conformation with four folded 
repeats and the unfolded C-cap. To validate this hypothesis, equilibrium unfolding 
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VI 
experiments of NI3 without C-cap and a NI3C variant with a more stable C-cap 
(Mutant 5 and 6) were performed. The results confirmed the interpretation that the 
wild-type C-cap is less stable and therefore prone to unfold first. An engineered C-cap 
(Mutant 5 and 6) further improved the stability of the DARPin variants and did not 
show this equilibrium intermediate. This C-cap can now be used for biotechnological 
applications.  
 
 
 
 
Zusammenfassung 
 
VII 
Das ‘Problem der Proteinfaltung’, d.h. das Verstehen der einzelnen Schritte des 
Proteinfaltungsweges, ist eine der anspruchvollsten Fragestellungen der Biochemie. 
Daher ist die Kombination von Theorie und Praxis ist unerlässlich, um die 
Mechanismen von Proteinfaltungsreaktionen zu erforschen. 
In dieser Dissertation wird die biophysikalische Charakterisierung von künstlich 
entwickelten Ankyrin Repeat Proteinen (Designed Ankyrin Repeat Proteins, 
DARPins) und deren Analyse durch theoretische Modelle vorgestellt. Repeat Proteine 
bestehen aus sich wiederholenden Struktureinheiten in einer nicht-globulären, 
gestreckten Anordnung, was sie grundlegend von den meisten in der Proteinfaltung 
untersuchten Proteinen unterscheidet und sie zu einer interessanten Proteinklasse für 
Faltungsstudien macht. 
Die hier verwendeten Ankyrin Repeats basieren auf einer Konsensussequenz von 
natürlichen Ankyrinproteinen und dienen damit als Modell für die Faltung dieser 
Proteine. 
Im ersten Teil der Dissertation wurden sechs verschiedene DARPins mit einem bis 
sechs internen Repeats sowie jeweils zwei terminalen Capping Repeats konstruiert 
und mittels Lichtstreuung, Zirkulardichroismus- und Fluoreszenz-Spektroskopie 
analysiert. Die längeren DARPins (> fünf repeats) waren jedoch so stabil, dass es 
nicht möglich war, sie in 8 M GdnHCl komplett zu entfalten; aus diesem Grund 
wurden die kinetische Experimente lediglich mit den kürzeren drei DARPins 
durchgeführt. Die Chevron Plot Analysen zeigen deutliche Abweichungen vom Zwei-
Zustands-Faltungsmodell, weshalb von den kooperativen Faltungsmodellen ein Drei-
Zustands-Mechanismus mit on-pathway Intermediat suggeriert wird. Jedoch liefert 
die globale Analyse der Gleichgewichtsdaten aller sechs DARPins zusammen mit den 
kinetischen Daten der kleineren drei DARPins anhand eines Ising-ähnlichen Modells 
weiterführende Einblicke in mögliche parallel ablaufende Faltungswege. Dieses 
Modell erlaubt die Erstellung einer Energielandschaft zu jeder Denaturierungsmittel-
Konzentration für die DARPins. Gemäss der Energielandschaft wäre bei hoher 
Denaturierungsmittel-Konzentration ein Intermediärzustand mit gefalteten internen 
Repeats und entfalteten Capping Repeats fast so stabil wie das komplett entfaltete 
Protein.  
Im zweiten Teil dieser Dissertation wurden sowohl DARPins mit modifizierten C-
terminalen capping repeats als auch ohne capping repeats konstruiert. Die Bedeutung 
der capping repeats für die Löslichkeit und die Aggregationstendenz wurde bewiesen. 
Da sich der C-terminale Capping Repeat in Molecular Dynamics Simulationen zuerst 
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entfaltete, wurde ein C-cap entworfen, welcher dem Protein ähnliche Löslichkeit und 
sogar höhere Stabilität verlieh. Die C-cap-Stabilität wurde in silico ermittelt und 
durch Experimente bestätigt. NI3C zeigte ein stabiles Intermediat in experimentellen 
Gleichgewichtsübergängen. Anhand der Simulationsergebnisse wurde angenommen, 
dass dieses Intermediat eine Konformation darstellt, in der vier Repeats gefaltetet 
sind, während der C-cap entfaltet ist. Zur Validierung dieser Hypothese wurden 
Gleichgewichtsübergänge mit NI3 ohne C-cap und einem NI3C Varianten mit einem 
stabileren C-cap (Mutante 5 und 6) durchgeführt. Die Ergebnisse bestätigten die 
Interpretation, dass der Wildtyp C-cap weniger stabil ist und daher dazu tendiert, 
zuerst zu entfalten. Ein engineered C-cap (Mutante 5 und 6) konnte die Stabilität der 
DARPins weiter erhöhen und zeigte kein Equilibrium-Intermediat. 
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Introduction 
1.1 Repeat proteins 
 
Repetitive sequence segments occur in at least 14 % of all proteins (ranging from 
short amino acid repetitions to large repetitions containing multiple domains).1 In the 
last two decades, a set of protein structures emerged that contain repeating structural 
units. These folds are termed solenoids, spirals, coils, supercoils, coiled folding 
domains and protein repeats, among other names.2  
They can be found in all phyla, more commonly in eukaryotic organisms than in 
prokaryotic ones, and in metazoans more than in the rest of the eukaryotes. Apart 
from their high frequency among known sequences, repeat proteins have also many 
different functions for similar repeat types. The most common function is that of 
binding to proteins involved in processes like protein transport, protein-complex 
assembly and protein regulation. 
A repeat protein comprises repeating structural units that form three-dimensional 
multirepeat assemblies. These assemblies are arranged in such a way, that the 
polypeptide chain forms either a linear array or a continuous superhelix, where the 
repeats are arranged about a common axis (see Figure 1).2,3 Most repeat proteins 
exhibit therefore an elongated and nonglobular shape. 
 
Fig. 1: 
Structure of the D34 
region of human Ankyrin-
R (PDB code 1N11). This 
12 AR region is one of 
the biggest AR proteins 
and illustrates the 
continuous superhelix.4 
 
For some repeat types, there is no theoretical limit on the repeat number, as adding 
repeats is not sterically obviated. Such an “open” structure presents an expanded 
solvent-accessible surface that is ideal for binding large substrates as proteins and 
nucleic acids.  
A repeat unit is formed of two, three or four elements of secondary structure linked by 
a short hairpin and the repeat families can be classified into three major structural 
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types (Figure 2): all α (armadillo/HEAT and TPR-like repeats), mixed α/β (leucin-
rich and ankyrin repeats) or all−β (β-propeller and β-trefoil with radial axis, β-strand 
repeats arranged along linear axis). The most prominent members are the ankyrin 
repeat (AR), armadillo repeat (ARM), leucine-rich repeat (LRR) and tetratricopeptide 
repeat (TPR). 
 
Fig. 2: 
Schematic diagrams of 
repetetive structural units in 
solenoid proteins. Helices 
are shown as red cylinders, 
β-strands are shown as 
magenta arrows and the 
connecting loops are shown 
in green according to Kajava 
(2000). The next repeat is 
shown in grey.2 
 
Solenoid proteins exhibit the least complicated relationship between a sequence and 
the corresponding three-dimensional structure, i.e. the lack of contacts between units 
distant from each other in primary structure. The structures are stabilized by 
hydrophobic interactions between neighboring repeats (stacking interactions). 
The simple and fundamentally different structure from globular proteins makes the 
repeat proteins an interesting object for protein folding studies. 
 
1.1.1 Ankyrin repeat proteins and DARPins 
 
The ankyrin repeat (AR) is one of the most frequently observed protein 
sequence motifs. These repeats got their name from one of the proteins in which they 
were first found, the human erythrocyte protein ankyrin, containing 24 AR. 
Erythrocyte ankyrin attaches the spectrin skeleton (membrane skeleton) to band 3, the 
anion-exchange protein.5 
AR proteins appear in nearly all phyla; apart from animals and yeast, they were also 
found in a plant protein and some prokaryotes and have even been noted in viruses 
such as poxviruses, variola, vaccinia and mouse mammary tumor virus.6 The AR was 
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found in > 3000 proteins, including cyclin-dependent kinase (CDK) inhibitors, 
transcriptional regulators, cytoskeletal organizers, spider toxins, in mitochondrial 
enzymes, nuclear cell cycle regulators, i.e. in various intra- and extracellular milieus 
(see also Fig. 3). 
The ankyrin repeat consists of two antiparallel α-helices preceeded by a short turn 
and followed by a loop. They are arranged to a superhelical structure with an 
extended binding groove that is formed by the loops (anti-parallel β-sheet) and the 
helices. 
The ubiquitousness of ankyrin repeat proteins and their high binding affinities led to 
the decision in our group to use the AR as protein scaffold for the generation of 
designed protein-binding molecules. The design of artificial ankyrin repeat proteins 
(DARPins) will be discussed in the subsection 1.2.5.1. 
 
 
 
 
 
 
Fig.3: 
Ankyrin repeat 
proteins with high-
resolution structures 
in the PDB. The 
repeats have been 
colored differently to 
illustrate the packing 
interactions present 
in this fold. Natural 
AR proteins (a) – 
(m) and designed 
AR proteins (n) – (p) 
according to Mosavi 
et al.7 
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1.2 Principles of Protein Folding 
 
Understanding the process how each newly synthesized peptide chain finds its 
way to a unique active conformation has fascinated scientists for decades. A solution 
of this “folding problem” is of enormous intellectual importance and would provide 
the missing link in the flow of information between a gene sequence and the 3-D 
structure of a protein, and then ultimately, its function. 
Apart from the basic interest in the mechanism, several far-reaching implications in 
investigating protein folding do exist; for example, improving structure prediction 
algorithms and methods for de novo design of protein folds that did not evolve by 
nature, as well as fields ranging from medicine, as i.e. misfolded proteins of brain 
diseases, to nanotechnology, i.e. single molecule protein measurements.8 
The graph in Fig. 4 shows the number of publications in the field of protein folding 
per year, and pictures therefore the development in the field of understanding protein 
folding mechanisms over the last 45 years. While in the seventies there were very few 
protein folding studies available, in the beginning of the nineties the amount of 
publications in the field of protein folding increased tremendously.  
In the late 50’s, Christian B. Anfinsen denatured Ribonuclease A in 8 M urea with β-
mercaptoethanol and discovered that, when renaturing the protein, it obtained back its 
biologically active state. This observation proved that the information necessary to 
specify the 3-D-structure of Ribonuclease A, is encoded in the amino acid 
sequence.9,10 Cyrus Levinthal then addressed the question about how proteins can find 
their way to the native state. As there are an astronomical number of possible 
conformations for a protein to adopt, e.g. if we have only three conformations per 
amino acid, then we have 3100 ≈ 1048 possibilities, the unbiased search through all of 
these possibilities would take by far too long for a protein to fold.11 This phenomenon 
 
Fig. 4: 
The number of manuscripts published per 
year (1970 – 2007) with the keywords ‘protein 
folding’ in either the title or the abstract. The 
data were taken from the Web of Science 
database. 
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was called the “Levinthal paradox”. It is a logical step to argue that there must be 
defined pathways to facilitate the choices to reach the folded state. 
After the awareness that proteins need to find the “right” pathway in order to reach 
their native structure, several models for the mechanism of folding have been 
proposed as summarized in Fig. 5. Anfinsen’s original experiments demonstrated that 
proteins fold spontaneously and reversibly into their native conformation. The 
nucleation growth model proposed that certain residues adjacent in sequence form a 
nucleus from which the native structure then is form in a sequential manner. The 
framework model, however, suggested that first all secondary structure elements form 
and that these then fold into the final native structure. The molten globule or 
hydrophobic collapse model assumes, that the proteins form first a collapsed 
intermediate species, and search then the native state. Finally, the Jigsaw model 
suggests that each protein molecule could fold by a different path.8 
 
 
 
 
 
 
 
Fig.5: Early models for mechanisms of 
folding according to Radford (2000).8 
 
Later on with the development of new experimental techniques and theoretical 
methods, major advances were made in elucidating the folding mechanisms that are 
termed the “new view of folding”.  
Maybe the most important point in the perception of folding today is that there is not 
a single, specific folding pathway. Instead, a multidimensional energy landscape 
better describes the folding process. Such an energy landscape allows the protein to 
follow different ways to the native state, however some of them must be much more 
populated than others (Fig. 6). Such an energy landscape does not contradict the older 
classical models. However, the classical models concentrate on the definition of the 
intermediates, while the energy landscape aims to summarize the process in a more 
global view. 
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Fig. 6: Schematic diagram of a folding energy 
landscape. Denatured molecules at the top of the 
funnel might fold to the native state by a myriad 
of different routes, some of which involve 
transient intermediates (local energy minima) 
whereas others involve significant kinetic traps 
(misfolded states). For proteins that fold without 
populating intermediates, the surface of the 
funnel would be smooth.8,12 
 
 
1.2.1 Two-state model  
 
In the two-state model of protein folding, the proteins are believed to adopt 
only two states: native (N) and unfolded (U). Such a behavior has been observed for 
many small single-domain proteins with less than 100 residues.   
 
1.2.1.1 Thermodynamics and kinetics in the two-state case 
 
This scheme (1) describes the conformational equilibrium in the two-state 
model.  
 
  (1) 
The reversible folding and unfolding is assumed to be a fully cooperative reaction 
such that no intermediates accumulate. The most important thermodynamic parameter 
characterizing a reversible equilibrium between the native and unfolded state is ΔG°, 
the difference in the free energy between the folded and the unfolded state. ΔG° is 
related to the equilibrium constant K° (by equations (2) and (3)).  
 
ΔG° = - RT ln K°     (2) 
K° = [U] / [N]       (3) 
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Plotting the spectroscopic signal of a certain protein as a function of the denaturant 
concentration yields the equilibrium transition curve (Fig. 7). 
 
 
 
Fig. 7: Equilibrium unfolding 
transition of a two-state protein. The 
pre- and post-transition baselines are 
shown by dotted lines. The transition 
midpoint Dm is at 2 M urea. Adapted 
from Jelesarov 13 
 
ΔG° can be calculated by fitting the data points of the equilibrium transition using 
equation (4). 
 
! 
Sobs D( ) = SU + mU D[ ]( ) fU + SN + mN D[ ]( ) fN   (4) 
k u and k f are the microscopic rate constants for the folding and unfolding reactions 
(see scheme (1)). The single observable macroscopic rate constant λ is derived as 
 
λ = k u + k f        (5)  
 
and the equilibrium constant K° is defined as  
 
K° = k f / k u        (6) 
 
Plotting the macroscopic rate constants kobs as a function of the denaturant 
concentration, provides the so-called chevron plot, as shown in Fig. 8. The linear parts 
of the chevron plot are called folding and unfolding limbs. Linearly extrapolating the 
limbs to 0 M denaturant concentration (see equations (5) and (7)) yields the 
microscopic rate constants ku and kf in absence of denaturant, that are used to 
characterize the folding and unfolding kinetics of a certain protein. Generally, taking 
into account also more complex kinetics in which one has n states, for all 
! 
kij  between 
state i and state j (with i=1,…,n , j=1,…,n and j≠i ), the relation 
 
! 
lnkij = lnkij
0 + mij D[ ]       (7) 
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is assumed, i.e. a linear dependence of the logarithm of the rate on the denaturant 
concentration, where 
! 
kij  represents the denaturant-dependent rate constant, 
! 
kij
0
 the rate 
constant in the absence of denaturant. In the two-state case we have two states, the 
unfolded state 1 and the folded state 2. The unfolding rate k u can be expressed as k12 
and the folding rate k f  as k21. 
 
 
Fig. 8: 
Chevron plot of a two-
state protein. The 
extrapolation to 0 M 
denaturant is shown in 
dashed lines. Adapted 
from Jelesarov 13 
 
 
1.2.2 Three-state models 
 
For some small proteins, as i.e. the four-helix bacterial immunity protein 
Im714,15 or the α-amylase inhibitor tendamistat16, but commonly for larger proteins 
(more than 100 residues) three-state transitions involving an intermediate state have 
been detected (scheme (8)). 
 
     (8) 
 
The corresponding equations to derive ΔG° and further thermodynamic parameters 
are shown in the results. 
 
1.2.2.1 Kinetic three-state models 
 
The possible three-state mechanisms are the triangular (9), the linear on-
pathway intermediate (10) and the linear off-pathway intermediate mechanism (11). 
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    (9) 
 
   (10) 
 
  (11) 
Since all three mechanisms shown in scheme (9) to (11) give rise to experimental 
observable rate constants, it is impossible to exclude the triangular mechanism on the 
basis of spectroscopic measurements of the folding kinetics. However, special double 
mixing techniques as the interrupted refolding assay by Schmid17 allow to distinguish 
between the on-path way and the off-pathway mechanism. The characteristic 
equations for the three-state mechanisms, i.e. linear quadratic equations involving the 
macroscopic and microscopic rate constants, and the analytical solutions of these 
equations are summarized in Buchner et al18 and the derivation of the kinetic 
parameters are shown in the Results in chapter 2.1.  
 
1.2.3 Modular Ising Model 
 
The Ising model is an alternative to the classical cooperative models and gives 
more insights into possible folding mechanisms. Originally, this simple model is used 
to describe the effects of magnetization in the context of statistical mechanics. Ising-
like models fully describe the thermodynamics of ferro-magnetic materials. Applied 
to the folding problem of DARPins an Ising-like model was developed and makes the 
following assumptions. 
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On the one hand, each repeat of a DARPin is considered as an independent two-state 
folding unit with a free energy of unfolding that depends linearly on the denaturant 
concentration 
! 
D[ ]. On the other hand, adjacent folded repeats interact by a stabilizing 
potential 
! 
J , whose magnitude is independent of 
! 
D[ ], but requires that both repeats 
are folded. 
As our DARPins have capping repeats (symbolized by a rectangle) of different 
stabilities than the one of the internal full-consensus repeats (symbolized by an oval), 
two different free energy terms 
! 
"G
0  and 
! 
"G
0
'  have been introduced. A cartoon of a 
potential intermediate state of a DARPin with three internal repeats is shown in 
Figure 9. A detailed description of this model is found in the Results section 2.1. 
 
Fig. 9: Cartoon representation of an intermediate state 
of a DARPin with three internal full-consensus 
repeats. The folded capping repeat is shown as a 
rectangle, the folded internal repeats as ovals, an 
unfolded capping repeat is represented by a deformed rectangle, the interaction potential is shown as a 
bar and the missing interaction potential as an empty bar. The sum of the individual energy terms, 
describes the total energy E of this intermediate state: Ε = ΔG’ +J +ΔG +J +ΔG +J +ΔG+0 +0. 
 
 
1.3 Protein Folding studies of natural AR proteins 
 
Several natural AR proteins have been previously investigated in folding 
studies.  
One of the smallest AR proteins with a known structure is the tumor 
suppressor protein p16 with four AR. This protein is a member of the INK4 family of 
inhibitors of the cyclin D-dependent kinases, CDK4 and CDK6, that are involved in 
the key growth control pathway of the eukaryotic cell cycle. In tumors, p16 is 
frequently mutated and the cells can thus proliferate. An extensive thermodynamic19 
and kinetic analysis as well as a phi-value analysis allowed to state a sequential 
unfolding mechanism, where the N-terminal repeats 1 and 2 unfold first, and then the 
C-terminal repeats 3 and 4. The phi-value analysis is a method that has been 
introduced by Fersht, and makes use of thermodynamic and kinetic parameters in 
order to probe the conformation of the folding transition state of proteins.20 
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Unfortunately, refolding measurements were not possible, therefore no data exist 
about the folding mechanism.21 The protein is very unstable and sensitive to point 
mutations with respect to its aggregation behavior. This vulnerability might provide 
one explanation for the frequency of p16 point mutations when analyzed in tumor-
infected tissue.19 A MD simulation study was consistent with the sequential unfolding 
mechanism and suggested two on-pathway intermediate states.22 It was also found 
that the autonomous folding unit of the p16 protein consists of two repeats, i.e. the C-
terminal repeats 3 and 4, p16C can fold independently, without the rest of the protein 
p16.23 
The tumor suppressor protein p19 has five AR and belongs to the same family 
as p16. While urea-induced unfolding transitions by far-UV CD and phenylalanine 
fluorescence suggested a two-state mechanism, the unfolding of p19 followed by 2D 
1H-15N HSQC spectra revealed a third species at moderate concentrations of urea.24 
Further intensive analysis of the folding and unfolding kinetics showed that this 
intermediate must be on-pathway and NMR H/D exchange experiments allowed 
structural speculations about this intermediate, i.e. the C-terminal repeats ANK3-5 are 
folded, while the N-terminal repeats 1-2 are unstructured.25  
 The third most intensively investigated natural AR protein for protein folding 
studies is the Drosophila melanogaster Notch receptor domain, a protein domain 
containing seven AR. The Notch protein signals by converting a transcriptional 
repression complex into an activation complex. The activity is modulated by 
interaction between the intracellular portion of the Notch receptor and a number of 
cytosolic and nuclear effector proteins, such as Suppressor of Hairless, Deltex, EMB-
5 and Skip.26 Numerous publications27,28,29,30,31,32,33,34 give insight into many different 
aspects of this protein domain. 
 
Fig. 10: The structure of the 
Drosophila melanogaster Notch 
receptor domain. The first 
repeat, which does not adopt an 
ankyrin-repeat fold, is on the 
left. 
 
Sequence alignments show that only repeat 1 to 6 have high similarity, while the 
seventh repeat exhibits lower similarity to the consensus sequence. The crystal 
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structure (Fig. 10) revealed that the seventh, C-terminal repeat adopts a regular 
ankyrin fold, but the first N-terminal repeat appears to be largely disordered.26  
 In another study with the mouse Notch homolog the higher stability of the C-
terminal repeats was confirmed, as only repeats 4 to 7 were resistant to degradation 
during crystallization. The crystal structure showed a preservation of the typical 
ankyrin fold also for the poorly conserved seventh AR,35 as seen in the Drosophila 
Notch domain. 
The thermodynamic study of a series of deletion constructs containing subsets 
of the seven ankyrin repeats of the Drosophila Notch receptor showed that the 
stability increases linearly with the repeat number. Using an 1D Ising model for 
folding, an energy landscape for protein folding was determined.36 To a good 
approximation, stabilities of each construct can be described as a sum of energy terms 
associated with each repeat. The magnitude of each energy term indicates that each 
repeat is intrinsically unstable but strongly stabilized by interactions with its nearest 
neighbors. A linear regression analysis of the stabilities versus repeat number yields 
an average stability of -2 kcal/mol for each single repeat and also shows that a single 
repeat of the Drosophila Notch receptor should be intrinsically unstable (+5.5 
kcal/mol).36 
Kinetic analysis of the full length construct of Notch, Nank1-7Δ (a 10 residue 
shorter construct with an N-terminal His6 tag, where two prolines in the 7th repeat are 
omitted), provided insight into the folding and unfolding mechanism. Both the 
refolding and unfolding kinetics were described by two exponential phases, i.e. when 
plotting the rates against denaturant concentration, a non-linear v-shaped chevron plot 
is defined for both phases. These two chevron plots, together with the unfolding 
amplitudes (the extent of the signal change in a kinetic measurement) are consistent 
with a sequential three-state model. Thus, similar to the study of p16 and p19, the 
Notch receptor domain shows a complex folding mechanism, i.e. an intermediate state 
could be detected and is believed to occur on the path between the folded and the 
unfolded state (on-pathway).37  
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1.4 Protein Folding studies of designed consensus repeat proteins 
 
1.4.1 Designed AR, LRR and Armadillo repeat proteins 
 
In our group, three different repeats were used for consensus design, the 
ankyrin repeat38, the leucin-rich repeat39 and the armadillo repeat40. It was found 
when using AR for consensus design, highly stable binding molecules can be obtained 
that can then be used together with selection technologies such as phage display and 
ribosome display. Additionally, the AR proteins (DARPins) could be expressed in 
very high yields in soluble form in the cytoplasm (> 200 mg/l shake flask culture). 
The AR fold does not rely on cysteines or disulfide bridges, that require an oxidizing 
environment to be formed correctly. If AR proteins had to form disulfide bridges, 
expression would have to be directed to the periplasm, as is done when expressing 
antibody fragments. 
Ankyrin repeat protein libraries were constructed, where the N- and C-terminal 
capping repeats from mouse GA-binding protein (GABPβ1 subunit) were used. The 
internal repeats were designed using a consensus strategy.38,41,42 The design strategy 
was based on sequence alignments using SMART, GenBank and PFAM databases. 
The consensus sequence was defined by the most frequent residues and further 
refined using structural data. In this way potential target interaction residues and 
framework residues were defined. While the framework positions were left constant, 
the chosen interaction residue positions, which are part of the β-turn and the first α-
helix, were allowed to vary. When I started my project, also a full-consensus AR just 
had been designed, where all the seven variable interaction residues had been fixed 
according the same design strategy. These design choices are discussed in chapter 2.1. 
 
1.4.2 Designed TPR proteins 
 
Similarly to our design of artificial ankyrin repeats, Regan and coworkers 
designed an artificial tetratricopeptide repeat (TPR).43,44,45 Each repeat is composed of 
two helices and has almost the same number of residues as the ankyrin repeat. The 
designed TPR protein contains no loops and one additional “solvating” helix at the C-
terminus that is important for solubility as the C-terminal capping repeat in the AR 
protein design (Fig. 11).43 
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Seven TPR proteins were constructed based on the same consensus containing 
one to ten consensus repeats (CTPR1 to CTPRa10).46,47 Thermodynamic as well as 
kinetic measurements showed similar results to our full-consensus DARPin series. 
The TPR protein series was described by a one-dimensional Ising model.47 This 
theoretical model was able to predict the protein stability in detail. The conclusion 
was that folding and unfolding of TPRs, and likely of all repeat proteins, does not 
conform to the all-or-nothing, folded-or-unfolded, two-state transition that is 
generally assumed for small globular proteins. Instead, the Ising description assumes 
the existence of partially folded configurations with significant statistical weight.47  
 
 
Fig. 11: Structure of the consensus 
tetratricopeptide repeat (TPR) proteins. (A) 
CTPR1. (B) CTPR2. (C) CTPR3. Repeat 1 
is shown in yellow, repeat 2 in red, repeat 
3 is blue and the solvating helix is green. 
(D) The amino acid sequences of CTPR 
proteins. Adapted from Main et al.46 
 
This 1D Ising model inspired us to use a similar model for studying our 
DARPins series and these results will be shown in the Results section 2.1. 
 
 
1.5 The aim of the project 
 
Using the full-consensus designed AR, I constructed a series of six proteins 
with one to six internal repeats, flanked by a C-terminal and N-terminal capping 
repeat according to the DARPin library construction. These fully designed AR 
proteins constitute an average structure for all natural AR and therefore serve as a 
model AR to extensively study the folding mechanism of AR proteins. Since natural 
ankyrin repeat proteins vary in sequence and each repeat has its intrinsic different 
stability value, no general conclusions for repeat proteins can be drawn. Our designed 
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proteins, however, have identical internal repeats and represent thus a model system 
for the study of repeat proteins. 
While we were interested to see the correlation between stability as well as 
folding rate and repeat number, we also wanted to analyze the folding mechanism in 
detail. The most interesting, but also most difficult question was to find informations 
about the structure of the intermediate states in the full-consensus DARPin folding 
mechanism.   
Two collaborations completed this folding study. One the one hand, molecular 
dynamics unfolding simulations of three full-consensus DARPins were carried out 
and gave us suggestions for further experiments. MD simulations showed that the C-
terminal capping repeat (C-cap) unfolded first. On the basis of this result, experiments 
were designed in order to study the unfolding of the C-cap. On the other hand, an 
alternative folding model (Ising-like) was developed to study the thermodynamics of 
the whole series of the six DAPRins as one data set.  
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Results 
 
2.1 Folding and Unfolding Mechanism of Highly Stable Full Consensus Ankyrin 
Repeat Proteins (I)  
 
This chapter describes the thermodynamic and kinetic measurements of the six 
full-consensus DAPRins NI1C to NI6C. The classical two- and three-state models 
were used to fit the data, but also an Ising-like model was chosen to describe the 
thermodynamic data set. Surprisingly, this model is also able to predict the kinetics of 
the proteins and can therefore suggest several possible folding pathways. 
 
 
 
Wetzel, S. K., Settanni, G., Kenig M., Binz H. K. & Plückthun, A. (2008). Folding 
and Unfolding Mechanism of Highly Stable Full-Consensus Ankyrin Repeat Proteins. 
J. Mol. Biol. 376, 241-257 
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2.2 Characterization and Further Stabilization of Designed Ankyrin Repeat Proteins 
by Combining Molecular Dynamics Simulations and Experiments (II) 
 
 This chapter presents the results of molecular dynamics (MD) simulations with 
NI1C, NI2C, NI3C and several other DARPins. Analysis of the MD runs suggested 
that unfolding begins with the denaturation of the C-capping repeat. The MD 
simulation results inspired us to construct DARPins without the capping repeats. 
These experiments proved the importance of the capping repeats for solubility as well 
as support the unfolding mechanism suggested from MD simulations. Furthermore, 
six new C-capping repeats were designed. The stabilities were assessed measuring the 
equilibrium unfolding of the new proteins (NI1C and NI3C mutants) with substituted 
C-terminal capping repeats. The high stability of the full consensus repeat was 
explained on the basis of structural considerations (electrostatic interactions) and 
compared to the less stable N3C library members. 
 
 
 
*Interlandi, G., *Wetzel, S. K., Settanni, G., Plückthun, A. & Caflisch, A. (2008). 
Characterization and further stabilization of designed ankyrin repeat proteins by 
combining molecular dynamics simulations and experiments. J. Mol. Biol. 375, 837-
854 
 
* contributed equally 
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2.3 Stabilizing Ionic Interactions in a Sulfate Binding Ankyrin Repeat Protein (III) 
 
Here, the crystal structure of the full consensus DAPRin NI3C is determined 
and compared to two N3C library members. Further considerations are made to 
explain the high stability of the full consensus AR.  
 
 
 
Merz, T., Wetzel, S. K., Firbank, S., Plückthun, A., Grütter, M. & Mittl, P. R. E. 
(2008). Stabilizing ionic interactions in a full consensus ankyrin repeat protein. J. 
Mol. Biol. 376, 232-240 
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2.4 Stepwise unfolding of ankyrin repeats in a single protein revealed by atomic force 
microscopy (IV) 
 
Here the unfolding mechanism of the longest full-consensus DARPin NI6C is 
analyzed using mechanical pulling as unfolding force. The results suggest a sequential 
mechanism, where the repeats unfold individually. AR proteins are found in many 
different cellular functions, such as cytoskeletal organization, where mechanical stress 
and deformations may be involved. One example is a spectrin binding AR protein.  
In a similar study using the 12-repeat protein ankyrin-R it was shown that AR exhibit 
tertiary-structure-based elasticity and behave as a linear and fully reversible spring in 
single-molecule measurements by atomic force microscopy (AFM). These results 
have implications in the field of mechanotransduction, i.e. modulating activity of 
ankyrin-associated transporters in response to mechanical strain.30 
 
 
 
Li, L. W., Wetzel, S., Plückthun, A. & Fernandez, J. M. (2006). Stepwise unfolding of 
ankyrin repeats in a single protein revealed by atomic force microscopy. Biophys. J. 
90, L30-L32. 
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3. Protocols 
3.1 Equilibrium unfolding and refolding curve 
 
For the preparation of an unfolding curve, two buffer solutions have to be 
prepared: the native buffer for the protein and a stock solution of the denaturant 
(GdnHCl) dissolved in the same native buffer at the same pH. In order to determine 
the exact concentration of GdnHCl, the refractive index (N) of each solution is 
measured and the molar concentration of GdnHCl calculated using the formula 
57.147 * ΔN + 38.28 (ΔN)2- 91.6 (ΔN)3, where ΔN = N(GdnHCl-PBS solution) – 
N(PBS). The buffers have to be filtered through 0.22 µm filters. 
For a first measurement, 15 samples are usually sufficient: 5 points in the pre-
transition region, 5 in the transition region and 5 points in the post-transition region. 
A pipetting scheme is prepared in Excel with the desired final concentrations of 
denaturant. The denaturant stock solution is mixed with the native buffer in different 
ratios to obtain 15 buffer solutions. Then, to each buffer, a constant volume of highly 
concentrated protein solution is added and mixed by pipetting. For better accuracy the 
protein volume should be around 10 to 30 µl. The final protein concentration has to be 
high enough to provide a good CD or fluorescence signal. In the case of the DARPins, 
5-10 µM was necessary. For each denaturant concentration a buffer sample and a 
protein sample have to be prepared. The protein is equilibrated in the denaturant at the 
desired temperature that is used for the measurement.  
The samples are then measured in a CD spectrometer or fluorimeter. The 
measurement settings used for the DARPins are as follows:  
1) CD (Jasco J-715): standard sensitivity 100 mdeg, wavelength 222 nm, data 
pinch 5 nm, scanning mode continuous, response 4 sec, band width 2 nm, 2 
min measurement time. 
2) Fluorescence (PTI Alpha Scan spectrofluorimeter): excitation λ1 and emission 
spectrum λ2 − λ3, photomultiplier 800 V, slit size 5 nm, method – step size 1 
nm, integration time 0.5 s, averages 3 – shutters automatic, acquire emission 
scan – excitation 248 nm, emission 263,5 nm. Check the wavelength setting 
always by looking at the number indicated on the monochromator (emission 
λ2) and then, in case of necessity, correct the number in the corresponding 
window for the wavelength in the software. 
The solutions are filled into the cuvette, equilibrated at the desired temperature for 1 
min and then measured. The cuvette is not washed between each measurement, but it 
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is important to start with native buffer and then to continue with increasing denaturant 
concentrations. For fluorescence cuvettes it is best to use a Pasteur pipet with a silicon 
tubing on the tip to transfer the solution into the cuvette and to remove it in one step.  
In order to make sure that the protein is at equilibrium, the measurement is repeated 
after 2 days. If the signal remains the same, the equilibration time was enough. 
Usually equilibration overnight is sufficient. 
For the refolding curve the protein stock solution has to be unfolded first. The 
denaturant concentration at the beginning of the post-transition region of the 
previously measured unfolding curve is chosen for the preparation of the unfolded 
protein stock solution. After equilibration of one day (or the time necessary to reach 
equilibrium), a similar set of 15 buffer samples is prepared and a constant volume of 
the unfolded protein is added. The protein samples are equilibrated for another night 
and measured. 
For the data analysis, the buffer signal has to be deduced from the protein signal and 
plotted against the denaturant concentration. The curves can then be fitted using the 
two-and three-state folding models (equations see Appendix). The condition for 
reversible folding is fulfilled if refolding curve and unfolding curve overlay.  
In the case of fluorescence measurements, the analysis can be done in several ways: 
usually the maximal emission intensity is plotted versus the denaturant concentration, 
but also the area or the center of gravity under the emission spectrum can be 
calculated and plotted versus denaturant concentration.47,48 
 
3.2 Unfolding and refolding kinetics measured in a stopped-flow instrument  
 
Equivalent to the equilibrium measurement, two buffer solutions have to be prepared.  
For a first chevron plot, it is enough to have 6 points for the folding limb and 6 points 
for the unfolding limb, i.e. 12 buffer solutions with different denaturant 
concentrations. For measuring unfolding kinetics, native protein is mixed with 
denaturant. For refolding kinetics, unfolded protein is mixed with native buffer and 
denaturant buffers of lower denaturant concentration. A chevron plot can be measured 
in one day. For the determination of the denaturant buffer concentrations, the 
information of the equilibrium transition curve is needed. Unfolding is started from 
the denaturant concentration of the transition midpoint (Dm), refolding is performed 
from native buffer to the denaturant concentration below Dm. Reasonable volumes 
for the solutions are: 10 ml protein solution, 20-30 ml buffer of each concentration. 
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Depending on the spectroscopic probe, the protein stock concentration has to be 
determined. In the case of the DARPins, which are rich in α-helix, and therefore 
exhibit a strong CD signal at 225 nm, a 200 µM (2 mm path) or 50 µM (10 mm path) 
protein stock solution was prepared, depending on which cuvette path length was 
used. If a fluorophor is used for fluorescence detection, the concentration of the 
protein can be much lower to achieve a good signal.  
The stopped-flow instrument Pi-Star from Applied Photophysics has a cylindrical 
cuvette, with the dimensions 2 mm (deep) x 10 mm (long) x 1 mm (wide) and 80 µl is 
the minimal volume that has to be pushed through the cuvette in order to measure 
kinetics. Indeed, during my measurements, I used always a shot volume of 250 µl, i.e. 
three time higher than necessary. The cuvette can be turned, so that measurements in 
the 2 mm path as well as in the 10 mm path are possible. If you want to save protein, 
the 10 mm path is recommended.  
For the protein sample a 200 µl syringe and for the buffer solution a 2 ml syringe are 
used. Using these syringe volumes, a mixing ratio of 1:10, typical for protein folding 
measurements, is obtained. The schematic configuration of the stopped-flow system 
for single mixing experiments and double mixing experiments is represented in Fig. 
12. Single mixing is used for the classical folding and unfolding measurements, while 
double mixing can serve for interrupted refolding or unfolding measurements as 
described by Schmid et al.17 
 
 
Fig. 12: Schematic representation of the stopped-flow mixing units: single mixing and double 
mixing. At the position of absorbance detection, also CD detection is possible. 
 
1) Switch on the instrument and the lamp, the water bath and set the 
measurement temperature, then switch on the computer and wait 30 min for 
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heating up the lamp. Open the liquid nitrogen bottle to apply a pressure of 2 
bar on the instrument. 
2) Enter all the settings into the Pi-Star software. In the control panel window 
enter: CD (or Fluorescence), AutoPM, Logarithmic data acquisition, over 
sampling, external trigger, monochromator λ = 225 nm (for fluorescence: the 
corresponding excitation wavelength); in the details sub window: enter slit 
size 4 nm for entrance and exit slit (CD measurements, for fluorescence to be 
determined depending on fluorophore). 
3) Wash the syringes with water 10 times (using drive option) and measure the 
CD/Fluorescence signal in order to have a baseline value. 
4) Fill the syringes with native buffer (flush tubing) and measure the baseline. 
5) Then exchange the buffer against the native protein stock solution in the 
smaller syringe (200 µl volume), see Fig. 13. 
 
Fig. 13: Hamilton syringe used in the stopped-flow 
instrument π*: the 100 µl syringe can be used to obtain 
mixing ratios of 1:20.  
 
 
6) Measure the protein baseline, meaning that native protein is mixed with native 
buffer. This means that the tubings have to be flushed before the measurement 
to make sure that really the protein is pushed through the cuvette. Usually I 
needed to flush up to 10 times before measurement. 
7) Exchange the native buffer against denaturant buffer with increasing 
denaturant concentrations. The unfolding kinetics are measured for each 
denaturant concentration. For the change of the buffer solution, the “empty” 
option in the control software is used. Here the solution is not pushed through 
the cuvette, but shot into the waste directly. One can control the exchange of 
the buffer observing the stop syringe, when the buffer is completely 
exchanged, usually after five shots, the measurement can be started. 
First, the duration of the measurement has to be decided. Single shots are 
carried out. When the signal reaches a plateau, the reaction is over. Then, 
several shots are performed with a fixed measurement time. The number of 
repetitions depends on the measurement time: kinetics of 1 second have to be 
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repeated at least 14 times in order to have a good signal to noise ratio, kinetics 
of 20 seconds only 7 times. This is judged from the quality of the signal; the 
more repeats, the better the signal, but also more protein is used. 
8) The buffer syringe is washed and filled with native buffer, the protein syringe 
is filled with the unfolded protein solution, the tubings have to be flushed. 
9) The refolding kinetics are measured with buffers starting from 0 M denaturant 
(native buffer) to increasing denaturant concentrations. The last reaction is 
measured with a final denaturant concentration just below the equilibrium 
transition midpoint. 
10) The last measurement is the protein baseline of the unfolded protein: the 
buffer syringe has to be filled with a denaturant buffer of the same 
concentration as the protein solution, so that protein remains in the unfolded 
state.    
The protein baselines are important as they provide the value of the starting signal of 
the kinetic trace. In the case of 1:10 mixing ratios, the dead time of the instrument is 3 
ms. During this dead time a part of the un/refolding reaction can take place and will 
not be monitored with the photomultiplier. When the protein baseline signal is known, 
the amplitude of the full reaction can be determined, and any very fast phase in the 
dead time can be qualitatively detected.  
 
Further important issues: 
 
• Attachment of the tubings (flow lines) in the KSHU (kinetic syringe holding unit, 
water bath temperature controlled): 
When removing the cell block (metal unit containing the cuvette), the tubings 
connecting the cuvette with the syringes have to be unscrewed. When the cell block is 
fit to the instrument again, the tubings have to be attached in such a way, that there is 
not too much tension on them as the cell block is moved when changing the path 
length. The best solution is the following: shorter tubing from the protein syringe to 
the cuvette, longer tubing from the buffer syringe to the cuvette in order to save 
protein solution. 
 
• Positioning of the flow line entrances into the cuvette 
There is no logical explanation, but experiences from other groups and the company 
Applied Photophysics showed that the best kinetic traces are obtained when both the 
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solutions, the viscous denaturant solution and the less viscous solution enter on the 
same level into the cuvette. This case is obtained in the 2 mm path position. Less 
good results are obtained when one of the solutions enter from the top or the bottom 
of the cuvette, this is the case when the cuvette is turned to the 10 mm path position.  
As the stopped-flow instrument is designed to measure fast kinetics, it makes no sense 
to measure kinetics longer than 50 or 100 seconds. With longer measurement times 
diffusion effects can disturb the kinetic trace. The cuvette is open on both sides: the 
entrance from the syringes and the exit that leads to the stop syringe. When the 
measurement starts, the stop syringe closes one end of the cuvette, but the other end is 
still open. That explains why diffusion takes place when long measurements are done. 
Minimal diffusion effects for the 10 mm path measurements are observed when the 
viscous solution enters from the bottom of the cuvette. This means, either the tubings 
connecting cuvette and syringes or the syringe positions themselves have to be 
exchanged depending on which solutions are used. In unfolding kinetics the buffer 
syringe contains the more viscous solution, while in refolding kinetics the protein 
syringe contains the more viscous solution. 
For slower kinetics, manual mixing can be performed with the normal CD 
spectrometer or fluorimeter. 
 
• Denaturant solutions in tubings 
Don’t leave the instrument with denaturant solutions in cuvette and tubings for longer 
times: the denaturant crystallizes out and plugs the tubings. Very intensive washing is 
needed to unblock the tubings later on. 
 
• Determination of the dead time of the instrument 
The dead time depends on the mixing ratio determined by the syringe volumes. 
Therefore, one has to measure the dead time for each specific set up. The typical 
reaction used is the reduction of 2,6-dichlorophenolindophenol (DCIP) by L-ascorbic 
acid as described in Tonomura et al.49 Here 1 mol DCIP reacts with 1.1 mol ascorbic 
acid at pH 2. If ascorbic acid is in excess, a pseudo-first order reaction takes place and 
the absorbance intensity decreases exponentially. The rate increases proportionally 
with the ascorbic acid concentration. Equation (12) describes the relation between the 
observed rate constant k obs and the absorbance signal. 
Abs t = Abs init * exp (-k obs* t)     (12) 
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If the first observation of the absorbance signal takes place at the dead time td, then 
the absorbance at td will depend on k obs, therefore the dead time td can be extracted 
from the relation as follows (equation (13)): 
ln(Abstd) = ln(Absinit) –k obs * td      (13) 
This means, you measure at least five reactions at different concentrations of ascorbic 
acid, you fit the traces to a single exponential equation in order to obtain the observed 
rate constants k obs (Fig. 14), you plot ln(ΔAbs) versus k obs and you perform a linear 
regression with these data points (Fig. 15). The slope corresponds to the dead time td. 
 
 
 
 
Fig. 14: Kinetic 
traces of the DCIP – 
ascorbic acid reaction 
with five different 
concentrations of 
ascorbic acid. The 
black lines are the best fits to a single exponential equation. The red arrow indicates the dead time td. 
 
Fig. 15: Linear regression for the extraction of 
the dead time td. 
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4. Conclusions and Discussion 
 
In this thesis, a series of fully artificial AR proteins have been biophysically 
characterized. These proteins were previously designed using sequence alignments of 
natural AR proteins from several protein databases and were termed “full-consensus 
DARPins”.38 Such a full consensus AR sequence represents an average structure of all 
known natural AR and therefore serves as a model AR to study the general folding 
mechanism of AR proteins. 
We analyzed a series of six full-consensus DARPins (NI1C to NI6C) using the 
classical cooperative two-state and three-state folding models; furthermore we also 
developed an alternative (Ising-like) model to describe these proteins. In this model, 
we assume two different stability values for the repeats: the both capping repeats are 
less stable than the internal consensus repeats. 
Two major insights were obtained: although many AR proteins reveal a two-
state behavior in equilibrium folding experiments, all kinetic studies show that the 
mechanism is more complex. Our generalized AR proteins confirm these results. 
Second, the stability of the repeat proteins is determined by the unfolding rates. This 
observation was also made for the full-consensus TRP repeat proteins: with increasing 
repeat number, the unfolding rates decrease;45 but in the case of the full-consensus 
DARPins, the decrease in the unfolding rate was much more significant. 
The Ising model could describe our full-consensus DARPin system very well. 
Using this model, we could extrapolate the stability values for the larger DARPins 
(NI4C, NI5C and NI6C) as well as a maximal asymptotic denaturation mid-point of 
even larger DARPins NIxC (x ≥ 6). Also, the model allowed predicting the kinetics of 
NI1C, NI2C and NI3C. As it has been reported for the full-consensus TPR protein 
series, it is consistent with a more complex folding mechanism than the two-state 
case. Furthermore, the Ising model provides an energy landscape for each denaturant 
condition. With this landscape, the most probable folding and unfolding pathways are 
summarized.  
The most important observation is the following: at 6 M GdnHCl, the most stable 
state of NI3C is the fully denatured one, but also another state almost as stable 
coexists. This state consists of three folded central repeats and both terminal capping 
repeats unfolded. Such a detailed interpretation is not possible with the classical 
cooperative models. 
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Furthermore, the kinetic unfolding phases can be attributed to different pathways in 
the energy landscape. In the example of NI3C, there are three unfolding phases 
observed in the experiment. The pathway, which contains the states with the lowest 
energy values (blue pathway in Fig. 6(d)), can be contributed to the slowest unfolding 
phase. A fast unfolding phase can be explained by another pathway, where a state 
with higher energy value is crossed (green pathway in Fig. 6(d)). 
However, of course, further experimental data are needed to study the 
intermediate states in more detail. A possible technique is NMR spectroscopy. With 
this method the proteins can be studied in solution and in diverse solution conditions 
at equilibrium as well as in a time dependent manner (kinetic measurements). As 
NMR can give structural information, this is the technique of choice to study folding 
intermediates. In our case, the complication is the repetitive structure. As the internal 
repeats of the full-consensus DARPins have all the identical sequence, NMR peaks of 
these residues cannot be distinguished. A solution of this problem can be the selective 
labeling of single repeats. However, the construction of a DARPin with selective 
labeled repeats is technically not trivial and will be a future challenge. If the specific 
repeat labeling issue will be solved, it would be easy to monitor the H/D exchange of 
specific repeats. With this tool, equilibrium unfolding curves can be measured using 
NMR spectroscopy and more detailed informations of the structure of the 
intermediate states could be obtained. 
Another technique used to analyze the intermediate states more in detail, is the 
stopped-flow double jump experiment (interrupted folding and unfolding assays). 
This assay allows to examine whether the same intermediate is formed during 
unfolding and refolding.25 For the double jump unfolding assay, samples are 
withdrawn from the unfolding solution at different time intervals after the initiation of 
unfolding; these samples are transferred to standard refolding conditions, and the 
amplitudes of the biphasic refolding reactions are determined and the ratios of the 
amplitudes compared. The amplitudes are proportional to the concentrations of the 
intermediate species. However, this assay cannot be used, when the both folding steps 
show similar rates. In this case the amplitudes no longer reflect the concentration of 
the intermediate molecules.  Also, this assay does not give any structural information 
about the intermediate states. 
 
Apart from the fact that the full consensus design yielded extremely stable 
proteins when compared to natural AR proteins and to the unselected and selected 
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DARPin library members, another conclusion was that the C-terminal capping repeat 
is the limiting part for the stability of the whole DARPin. This is an important issue 
for the design of even more stable DARPins that are useful in biochemical 
applications, as e. g. DARPins as detection tools. 
 
In this thesis theory and experiment were combined by collaborations with 
physicists. It was shown that together, theoretical and experimental results open ways 
to deeper understanding of the ‘folding problem’. Both results alone are less 
meaningful. There is still plenty of space for further experiments.  
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5. Outlook and Perspectives 
 
Several projects are currently ongoing and will be discussed in this paragraph.  
 
The C-cap mutants NI3C Mut 5, NI3C Mut 6 and all six NI1C Mutants are 
interesting proteins for crystal structure determination. Analysis of the electrostatic 
interactions in these C-cap mutants could give further insight into the factors that 
determine the higher stability of these in comparison to other mutants containing 
fewer point mutations as well as in comparison to the DARPins containing the wild-
type C-cap.  
Furthermore, NI3C Mut 5 and NI3C Mut 6 form dimers to some minor extent 
(15 %), as seen in static light scattering and gel filtration experiments. Determination 
of the crystal structure might shed light on the interaction positions that form the 
protein-protein dimer. Such information could be subsequently be used for further 
design purpose. 
 
The stable C-cap Mutant 5 can now also be used to increase the stability of 
other DARPins that are less stable and therefore prone to oligomerize. A first trial is 
started with an EpCAM-binding DARPin by substituting the C-cap with C-cap mutant 
5. The transmembrane glycoprotein EpCAM is an epithelial cell adhesion molecule 
that shows abundant expression in many solid tumors, but only limited distribution in 
normal epithelial tissues. EpCAM-specific antibody therapeutics were shown to be 
promising in preclinical as well as clinical studies.50 Substituting the wild-type C-cap 
against the C-cap mutant 5 in EpCAM-specific high-affinity binders might decrease 
the tendency to form aggregates. The binders with wild-type C-cap will be compared 
to the binders with the new C-cap mutant 5. This approach might provide DARPin 
binders well suited as alternative scaffolds for tumor drug delivery. 
 
Another currently ongoing project is the use of NI6C as a bulky molecular 
linker. By employing a full-consensus DARPin as linker, inflexible ErbB2-targeted 
DARPin dimers will be constructed. ErbB2 is another transmembrane protein (a 
tyrosine-kinase coreceptor) that is abundantly expressed in breast and ovarian tumors.  
In order to mimic the structure of antibody arms with simple construction 
tools, we decided to introduce a bulky protein bridge between two DARPin 
molecules. For this purpose, we selected the nonspecific consensus DARPin 
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molecules with at least three-internal repeat length (i.e. NI3C and longer). The two 
ErbB2-specific binders are connected via a very short linker consisting of two 
residues to the N- and C-termini of the structured part of a nonspecific DARPin. This 
approach is expected to yield dimeric DARPin molecules where the specificity-
conferring moieties are separated by a sufficient distance (comparable to antibodies in 
the range of 30-100 Å). Nevertheless, sufficient degrees of flexibility and rotation are 
necessary, as the exact epitope and orientation of DARPins in complex with ErbB2 
receptor are not yet known. Instead of a short linker, a longer linker of (G4S)4 as well 
as the full-consensus DARPin NI6C is used. 
 
To investigate whether full-consensus DARPins of varying internal repeat 
numbers can be used as rigid standard proteins for quantitative distance measurements 
in single-molecule fluorescence experiments using Förster resonance energy transfer 
(FRET), FRET transfer efficiency distributions were measured for donor and acceptor 
dyes attached to the termini of freely diffusing DARPins. These constructs have been 
previously constructed for the attachment of a donor and an acceptor fluorophore at 
defined positions within the proteins. In two DARPins containing one and two 
internal repeats all lysine residues, except for one close to the N-terminus, have been 
replaced with arginines and an additional C-terminal cysteine has been introduced. In 
a third DARPin, NI3C, containing three internal repeats, both a N- and C-terminal 
cysteine have been introduced. 
The project comprised the construction (done by the diploma student J. 
Kirchholtes), the purification of the DARPins, their conjugation with fluorescent dyes 
and subsequent single-molecule FRET experiments under native and denaturing 
conditions as well as the determination of the effect of their modification on their 
thermodynamic stability by ensemble fluorescence experiments. The single-molecule 
FRET technique promises new insights into the folding and unfolding mechanism of 
proteins; however, it remains an open question, whether the full-consensus DAPRins 
are useful molecules to further fine-tune this method. 
 
In order to further validate the Ising-like folding model of our full-consensus 
DARPins as well as to explore further possibilities to gain informations about 
possible folding intermediates, a collaboration with Oliver Zerbe was started.  
Folding and formation of hydrogen bonds are intuitively linked. The 
measurement of exchange kinetics of amide protons therefore presents a convenient 
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method for studying protein folding. In principle, data for H/D exchange could be 
derived from NMR or MS spectroscopy. 15N labeling of proteins in combination with 
15N,1H correlation spectroscopy enables us to follow amide proton exchange with 
residue-resolution. These experiments are sensitive and applicable for larger proteins 
(i.e. proteins of more than 250 residues). The six full-consensus DARPins will be 
expressed in 15N medium for uniform labeling of the N-nuclei. The lyophilized two 
most stable NI3C C-cap mutants will be dissolved in D2O for H/D exchange 
measurements and 15N,1H correlation experiments recorded repeatedly to follow the 
signal decay due to the replacement of amide protons by deuterium. The exchange 
rates should depend on the stability of the hydrogen bonds, which are related to the 
overall stability of the folded protein, but also depend on the folding mechanism. If 
we assume a cooperative model, partial unfolding of the highly stable NI6C is 
extremely rare and therefore H/D exchange will be very slow. In contrast, NI1C is less 
stable and unfolds at intermediate temperatures, so H/D exchange is expected to take 
place more rapidly. However, if folding occurs according to the Ising model, where 
we assume that each repeat unfolds and refolds independently, the length of the 
protein as well as the stability of each internal repeat is expected to influence the 
exchange rate only marginally. Nevertheless, the stability of the capping repeats is 
different, and this difference is expected to yield similar exchange kinetics for the 
caps in both NI1C as well as in NI6C.  
It would also be interesting to measure H/D exchange of NI3C in 3 M GdnHCl 
in order to reveal details of the equilibrium intermediate states. 
If we label the C atoms of NI3C and the other full-consensus DARPins using 
13C medium, sequence-specific assignments might be possible because of the different 
sequences of the terminal capping repeats, and hence structural information of the 
capping repeats could be obtained and H,D exchange rates could be assigned to 
individual sites. 
 
As little information on structures of the folding intermediates of full-
consensus DARPins is presently available, a lot of work remains to be done. NMR 
could turn out to be a valuable method to reveal such information. 
Technological aspects, such as the usage of highly stable DARPins as detection tools 
and alternative scaffolds for drug delivery, will be further explored. 
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7. Appendix 
 
7.1 Abbreviations 
 
aa   amino acid 
AFM  atomic force microscopy 
ANK  ankyrin 
AR   ankyrin repeat 
CD   circular dichroism 
Chevron plot graph where the logarithm of the folding and unfolding rate is plotted 
versus the denaturant concentration 
DARPins designed AR proteins 
Dm  midpoint of denaturant concentration in chemical unfolding 
ΔG  difference in free energy between two states 
ΔH  difference in free enthalpy between two states 
GA  guanine-adenine 
GABPβ1 mouse guanine-adenine-binding protein β1 subunit 
GdnHCl  guanidinium hydrocloride  
HB  hydrogen bond 
IPTG  Isopropyl-β-thiogalactopyranoside 
LRR  Leucine-rich repeat 
NMR  Nuclear magnetic resonance 
MALS  Multi-Angle-Light Scattering 
MD  molecular dynamics 
PCR  Polymerase Chain reaction 
PDB  Protein Data Bank 
PFAM  Protein families database of alignments and hidden Markov models 
RMSD  root mean square deviation 
SC  surface complementarity 
SDS  Sodium dodecyl sulphate 
SMART Simple modular architecture research tool 
Tm  midpoint temperature in thermal unfolding 
TPR  tetratricopeptide repeat 
TPRA1 mechanosensitive transduction channel 
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7.2 List of Plasmids 
Plasmids used during the thesis: 
 
pPANK (HKB) 
pPRO (HKB) 
pEWT (HKB) 
pWTC (HKB) 
pSW_N1C 
pSW_N2C 
pSW_N3C 
pSW_N4C 
pSW_N5C 
pSW_N6C 
pSW_I3 
pSW_I4 
pSW_NI3 
pSW_NI4 
pSW_I3C 
pSW_I4C 
pSW_N1CMu1 
pSW_N1CMu2 
pSW_N1CMu3 
pSW_N1CMu4 
pSW_N1CMu5 
pSW_N1CMu6 
pSW_N3CMu1 
pSW_N3CMu2 
pSW_N3CMu3 
pSW_N3CMu4 
pSW_N3CMu5 
pSW_N3CMu6 
pJKN1CKR  
pJKN2CKR  
pJKmuA 
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7.3 Equations used for fitting of cooperative folding models 
 
For fitting the experimental data the software ProFit 6.0.6 was used. The equations 
are represented in a Pascal-like function definition. 
 
7.3.1 Equilibrium two-state fit 
7.3.1.1 Chemical unfolding, fitting parameters m, Dm 
 
function equil_2state_chem; 
 
description 
'y = ((m1+m2*x)+(m3+m4*x)*exp(m5*(x-m6)/R*T))/(1+exp(m5*(x-m6)/R*T));)', 
'2-state equil_chem'; 
 
defaults 
 a[1]:=0,active,'yf (signal folded)'; 
 a[2]:=0,active,'mf (slope of pretransition)'; 
 a[3]:=0,active,'yu (signal unfolded)'; 
 a[4]:=0,active,'mu (slope of posttransition)'; 
 a[5]:=0,active,'m (slope of transition)'; 
 a[6]:=0,active,'Dm (transition midpoint)'; 
 a[7]:=0,inactive,'R (gas constant)'; 
 a[8]:=0,inactive,'T (temp)'; 
  
begin 
 y := ((a[1]+a[2]*x)+(a[3]+a[4]*x)*exp(a[5]*(x-
a[6])/(a[7]*a[8])))/(1+exp(a[5]*(x-a[6])/(a[7]*a[8]))) 
end; 
 
7.3.1.2 Chemical unfolding, fitting parameters m, ΔG0 
 
function equ_2state_chem_deltaG; 
 
description 
'equil 2-state chem'; 
 
defaults 
 a[1]:=-13000,active,'An'; 
 a[2]:=120,active,'mn'; 
 a[3]:=-1270,active,'Bu'; 
 a[4]:=40,active,'mu'; 
 a[5]:=9000,active,'dG0'; 
 a[6]:=2500,active,'m'; 
 a[7]:=293.15, inactive, 'T'; 
  
var 
 
denat, dG, K, fn, fu, Sn, Su; 
  
begin 
 denat := x; 
 Sn:= a[1] + a[2]*denat; 
 Su:= a[3] + a[4]*denat; 
 dG := a[5] - a[6]*denat; 
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 K := exp(-dG/(1.9872*a[7])); 
 fu:= K/(1 + K); 
 fn := 1 - fu; 
 y := Sn*fn + Su*fu; 
end; 
 
7.3.1.3 Thermal unfolding, fitting parameters m, ΔH0 
 
function equil_2state_melting; 
 
description 
'2-state equil_melting'; 
 
defaults 
 a[1]:=0,active,'yu (signal unfolded)'; 
 a[2]:=0,active,'mu (slope of posttransition)'; 
 a[3]:=0,active,'yf (signal folded)'; 
 a[4]:=0,active,'mf (slope of pretransition)'; 
 a[5]:=0,active,'dH (delta H)'; 
 a[6]:=0,active,'Tm (melting point, K)'; 
 a[7]:=1.9872,inactive,'R (gas constant, cal/K*mol)'; 
  
var 
 
CDN, CDU, Ku, fu, fn; 
  
begin 
CDN := a[2]*x+a[1]; 
CDU := a[4]*x+a[3]; 
Ku := exp((a[5]/a[7])*(1/a[6]-1/x)); 
fu := Ku/(1+Ku); 
fn := (1-fu); 
y := fn*CDN+fu*CDU; 
 
end; 
 
7.3.2 Equilibrium three-state fit 
7.3.2.1 Chemical unfolding, fitting parameters m1, ΔG10, m2, ΔG20 
 
function equ_3state_chem_deltaG; 
 
description 
'equil 3-state chem'; 
 
defaults 
 a[1]:=600,active,'An'; 
a[2]:=-3,active,'mn'; 
 a[3]:=0.001,active,'Bi'; 
 a[4]:=1.2,active,'mi'; 
 a[5]:=7000,active,'Cu'; 
 a[6]:=-3,active,'mu'; 
 a[7]:=0.001,active,'dG01'; 
 a[8]:=0.7,active,'dG02'; 
 a[9]:=0.5, active,'m1'; 
 a[10]:=0.5, active,'m2'; 
 a[11]:=293.15, inactive, 'T'; 
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var 
 
denat, dG1, dG2, K1, K2, fn, fi, fu, Sn, Si, Su; 
  
begin 
 
 denat := x; 
 Sn:= a[1] + a[2]*denat;  
 Si:= a[3] + a[4]*denat;  
 Su:= a[5] + a[6]*denat;  
 dG1 := a[7] - a[9]*denat; 
 dG2 := a[8] - a[10]*denat; 
 K1 := exp(-dG1/(1.9872*a[11])); 
 K2 := exp(-dG2/(1.9872*a[11])); 
 fn := 1/(1 + K1 + K1*K2); 
 fi := K1/(1 + K1 + K1*K2); 
 fu:= K1*K2/(1 + K1 + K1*K2); 
  
 y := Sn*fn + Si*fi + Su*fu; 
end; 
 
7.3.2.2 Chemical unfolding, fitting parameters m1, K10, m2, Κ20 
 
function Equil_3_state; 
defaults 
 
a[1] := 90, active, 'Su'; 
a[2] := 3, active, 'u'; 
a[3] := 15, active, 'K°1'; 
a[4] := 15, active, 'K°2'; 
a[6] := 6.5, active, 'm2'; 
a[5] := 6.5, active, 'm1'; 
a[7] := 293.15, inactive, 'T'; 
a[8] := 90, active, 'Si'; 
a[9] := 500, active, 'Sn'; 
a[10] := -30, active, 'n'; 
 
begin 
  
    
y := 
((a[1]+a[2]*x)*a[3]*a[4]*exp((a[5]+a[6])*x/1.987/a[7])+a[8]*a[3]*exp(a[5]*x/1.987/a[7]
)+a[9]+a[10]*x)/(1+a[3]*exp(a[5]*x/1.987/a[7])+a[3]*a[4]*exp((a[5]+a[6])*x/1.987/a[7])
);end;   
       
end;  
 
7.3.3 Kinetics: Two-state chevron plot 
 
function chevron_2state; 
 
description 
'y = ln((kref*exp(mref*x)) + kunf*exp(munf*x))', 
'2-state chevron'; 
 
defaults 
 a[1]:=0,active,'kref (refolding rate)'; 
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 a[2]:=0,active,'mref (slope of refolding limb)'; 
 a[3]:=0,active,'kunf (unfolding rate)'; 
 a[4]:=0,active,'munf (slope of unfolding limb)'; 
  
begin 
 y := ln((a[1]*exp(a[2]*x)) + a[3]*exp(a[4]*x))  
end; 
  
7.3.4 Kinetics: Three-state chevron plot 
7.3.4.1 on-pathway intermediate 
 
function kin_3state_on_pathway; 
 
description 
'3-state on_pathway'; 
 
defaults 
 a[1]:=600,inactive,'k12'; 
 a[2]:=-3,inactive,'m12'; 
 a[3]:=0.001,inactive,'k21'; 
 a[4]:=1.2,inactive,'m21'; 
 a[5]:=7000,inactive,'k23'; 
 a[6]:=-3,inactive,'m23'; 
 a[7]:=0.001,inactive,'k32'; 
 a[8]:=0.7,inactive,'m32'; 
  
var 
 
denat, kUI, kIU, kIN, kNI, B, C, amp1, amp2; 
  
begin 
 
if (x<10) and (x>=0) then begin 
 denat := x; 
 kUI := a[1]*exp(a[2]*denat); 
 kIU := a[3]*exp(a[4]*denat); 
 kIN := a[5]*exp(a[6]*denat); 
 kNI := a[7]*exp(a[8]*denat); 
 B := -(kUI + kIU + kIN + kNI); 
 C := kUI*kIN + kUI*kNI + kIU*kNI; 
 amp1 := (-B-sqrt(B^2-4*C))/2; 
 y := ln(amp1); 
end 
  
else if (x<20)  and (x>=10) then begin 
 denat := x-10; 
 kUI := a[1]*exp(a[2]*denat); 
 kIU := a[3]*exp(a[4]*denat); 
 kIN := a[5]*exp(a[6]*denat); 
 kNI := a[7]*exp(a[8]*denat); 
 B := -(kUI + kIU + kIN + kNI); 
 C := kUI*kIN + kUI*kNI + kIU*kNI; 
 amp2 := (-B+sqrt(B^2-4*C))/2; 
  
 y := ln(amp2); 
end 
 
end; 
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7.3.4.2 off-pathway intermediate 
  
function kin_3state_off_pathway; 
 
description 
'3-state off_pathway'; 
 
defaults 
 a[1]:=600,active,'k12'; 
 a[2]:=-3,active,'m12'; 
 a[3]:=0.001,active,'k21'; 
 a[4]:=1.2,active,'m21'; 
 a[5]:=7000,active,'k23'; 
 a[6]:=-3,active,'m23'; 
 a[7]:=0.001,active,'k32'; 
 a[8]:=0.7,active,'m32'; 
  
var 
 
denat, kIU, kUI, kUN, kNU, B, C, amp1, amp2; 
  
begin 
 
if (x<10) and (x>=0) then begin 
 denat := x; 
 kIU := a[1]*exp(a[2]*denat); 
 kUI := a[3]*exp(a[4]*denat); 
 kUN := a[5]*exp(a[6]*denat); 
 kNU := a[7]*exp(a[8]*denat); 
 B := -(kUI + kIU + kUN + kNU); 
 C := kIU*kUN + kIU*kNU + kUI*kNU; 
 amp1 := (-B-sqrt(B^2-4*C))/2; 
 y := ln(amp1); 
end 
  
else if (x<20)  and (x>=10) then begin 
 denat := x-10; 
 kIU := a[1]*exp(a[2]*denat); 
 kUI := a[3]*exp(a[4]*denat); 
 kUN := a[5]*exp(a[6]*denat); 
 kNU := a[7]*exp(a[8]*denat); 
 B := -(kUI + kIU + kUN + kNU); 
 C := kIU*kUN + kIU*kNU + kUI*kNU; 
 amp2 := (-B+sqrt(B^2-4*C))/2; 
  
 y := ln(amp2); 
end 
 
end; 
 
7.3.4.3 triangular pathway intermediate 
 
function kin_3state_triangular; 
 
description 
'3-state triangular'; 
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defaults 
 a[1]:=600,active,'k12'; 
 a[2]:=-3,active,'m12'; 
 a[3]:=0.001,active,'k21'; 
 a[4]:=1.2,active,'m21'; 
 a[5]:=7000,active,'k23'; 
 a[6]:=-3,active,'m23'; 
 a[7]:=0.001,active,'k32'; 
 a[8]:=0.7,active,'m32'; 
 a[9]:=7000,active,'k13'; 
 a[10]:=-3,active,'m13'; 
 a[11]:=0.001,active,'k31'; 
 a[12]:=0.7,active,'m31'; 
  
var 
 
denat, kIU, kUI, kUN, kNU, kIN, kNI, B, g1, g2, g3, C, amp1, amp2; 
  
 
begin 
 
if (x<10) and (x>=0) then begin 
 denat := x; 
 kUI := a[1]*exp(a[2]*denat); 
 kIU := a[3]*exp(a[4]*denat); 
 kIN := a[5]*exp(a[6]*denat); 
 kNI := a[7]*exp(a[8]*denat); 
 kUN := a[9]*exp(a[10]*denat); 
 kNU := a[11]*exp(a[12]*denat); 
  
 B := -(kUI + kIU + kUN + kNU + kIN + kNI); 
 g1 := kNI*kIU + kNU*kIU + kIN*kNU; 
 g2 := kNU*kUI + kUI*kNI + kUN*kNI; 
 g3 := kUI*kIN + kIU*kUN + kUN*kIN; 
  
 C := g1 + g2 +g3; 
 amp1 := (-B-sqrt(B^2-4*C))/2; 
 y := ln(amp1); 
end 
  
else if (x<20)  and (x>=10) then begin 
 denat := x-10; 
 kUI := a[1]*exp(a[2]*denat); 
 kIU := a[3]*exp(a[4]*denat); 
 kIN := a[5]*exp(a[6]*denat); 
 kNI := a[7]*exp(a[8]*denat); 
 kUN := a[9]*exp(a[10]*denat); 
 kNU := a[11]*exp(a[12]*denat); 
  
 B := -(kUI + kIU + kUN + kNU + kIN + kNI); 
 g1 := kNI*kIU + kNU*kIU + kIN*kNU; 
 g2 := kNU*kUI + kUI*kNI + kUN*kNI; 
 g3 := kUI*kIN + kIU*kUN + kUN*kIN; 
  
 C := g1 + g2 +g3; 
 amp2 := (-B+sqrt(B^2-4*C))/2; 
  
 y := ln(amp2); 
end 
 
end; 
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